The synthesis and brain uptake in mice of the radioiodinated derivatives of N,N dimethyl-N' (iododimethoxyphenyl)-1,3-propanediamine, as well as the N-substituted derivatives of (iodoalkylphe nyl)isopropyl, iodoalkylphenylethylamine and 3,4-(methylenedioxy)phenyl-amphetamine (MDA) are de scribed. These compounds contain structural features of both IMP and HIPDM, the cerebral perfusion agents currently in clinical use. The radiolabeled analogs were obtained via the [I-125]I exchange method, or by [I-125]NaI treatment of the iodo free precursor in the presence of an oxidant. Following intravenous injection in mice, all compounds showed important radioactivity concentrations in the lungs and kidneys. The N-substituted (iodoalkylphenyl)isopropyl and iodoalkylphenyl-ethylamine derivatives displayed a high initial brain uptake (>1O%IDg(-1)) followed by a rapid clearance phase, resulting in lower brain to blood ratios as those reported for IMP and HIPDM. In contrast, N,N-dimethyl-N'-(iododimethoxyphenyl)-1, 3-propanediamine derivatives featuring the iodo substituent on the benzene carbon adjacent to the methyl amine group and the methoxy substituents on the 2,5- or 2,4-positions, showed low but more persistant brain uptake. Combined with fast blood clearance, this resulted in high brain-to-blood ratios at later time points. Among all compounds tested, the highest brain-to blood ratio was observed with compound N,N dimethyl N'-(6-iodo-3,4-dimethoxyphenyl)-1,3-propanedimine (27e), reaching a maximum of >20 at 12 h post injection. 1997 Elsevier Science Inc.